Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

被引：0
|
作者：
Makoto Natsume
Takaya Shimura
Hiroyasu Iwasaki
Yusuke Okuda
Mika Kitagawa
Yasuyuki Okamoto
Kazuki Hayashi
Hiromi Kataoka
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Angiogenesis; Biomarker; Gastric cancer; PlGF; Ramucirumab; VEGF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1037 / 1046
页数：9
相关论文
共 50 条
  • [1] Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
    Natsume, Makoto
    Shimura, Takaya
    Iwasaki, Hiroyasu
    Okuda, Yusuke
    Kitagawa, Mika
    Okamoto, Yasuyuki
    Hayashi, Kazuki
    Kataoka, Hiromi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1037 - 1046
  • [2] Plasma biomarker dynamics following ramucirumab treatment and survival analysis after ramucirumab treatment failure in patients with advanced gastric cancer.
    Ota, Yumiko
    Wakatsuki, Takeru
    Mashima, Tetsuo
    Takahari, Daisuke
    Chin, Keisho
    Ichimura, Takashi
    Ogura, Mariko
    Matsushima, Tomohiro
    Osumi, Hiroki
    Nakayama, Izuma
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Kawata, Naomi
    Horiike, Yuki
    Seimiya, Hiroyuki
    Fujita, Naoya
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [3] Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer.
    Takahari, Daisuke
    Wakatsuki, Takeru
    Mashima, Tetsuo
    Chin, Keisho
    Ichimura, Takashi
    Ogura, Mariko
    Matsushima, Tomohiro
    Osumi, Hiroki
    Nakayama, Izuma
    Ota, Yumiko
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Kawata, Naomi
    Horiike, Yuki
    Seimiya, Hiroyuki
    Fujita, Naoya
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [4] Ramucirumab monotherapy for advanced gastric cancer
    Yaqub, Farhat
    LANCET ONCOLOGY, 2013, 14 (12): : E495 - E495
  • [5] Ramucirumab: A Review in Advanced Gastric Cancer
    Greig, Sarah L.
    Keating, Gillian M.
    BIODRUGS, 2015, 29 (05) : 341 - 351
  • [6] Ramucirumab: A Review in Advanced Gastric Cancer
    Sarah L. Greig
    Gillian M. Keating
    BioDrugs, 2015, 29 : 341 - 351
  • [7] Analysis of predictive factors of ramucirumab plus paclitaxel for advanced gastric cancer.
    Fukuda, Naoki
    Takahari, Daisuke
    Osumi, Hiroki
    Matsushima, Tomohiro
    Nakayama, Izuma
    Wakatsuki, Takeru
    Ogura, Mariko
    Ichimura, Takashi
    Ozaka, Masato
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Chin, Keisho
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] Clinical utility of ramucirumab in advanced gastric cancer
    Chan, Matthew M. K.
    Sjoquist, Katrin M.
    Zalcberg, John R.
    BIOLOGICS-TARGETS & THERAPY, 2015, 9 : 93 - 105
  • [9] Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer: Preliminary results.
    Takahari, Daisuke
    Wakatsuki, Takeru
    Mashima, Tetsuo
    Ichimura, Takashi
    Chin, Keisho
    Ogura, Mariko
    Nakayama, Izuma
    Matsushima, Tomohiro
    Osumi, Hiroki
    Ozaka, Masato
    Suenaga, Mitsukuni
    Shinozaki, Eiji
    Seimiya, Hiroyuki
    Fujita, Naoya
    Yamaguchi, Kensei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [10] BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer
    Kubo, Tomohiro
    Kawano, Yutaka
    Himuro, Nobuaki
    Sugita, Shintaro
    Sato, Yasushi
    Ishikawa, Kazuma
    Takada, Kohichi
    Murase, Kazuyuki
    Miyanishi, Koji
    Sato, Tsutomu
    Takimoto, Rishu
    Kobune, Masayoshi
    Nobuoka, Takayuki
    Hirata, Koichi
    Takayama, Tetsuji
    Mori, Mitsuru
    Hasegawa, Tadashi
    Kato, Junji
    GASTRIC CANCER, 2016, 19 (03) : 827 - 838
12345